First-in-Human and Early Feasibility Studies with a Dual-Frequency IVUS Imaging System for the Assessment of Plaque Vulnerability Through Lipid and Fibrous Cap Characterization
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Shenzhen Vista Vision Medical Technology Co., Ltd.
- Royalty/Intellectual Property Rights - Shenzhen Vista Vision Medical Technology Co., Ltd.